152 related articles for article (PubMed ID: 19655168)
1. Aberrant DNA methylation of integrin alpha4: a potential novel role for metastasis of cholangiocarcinoma.
Uhm KO; Lee JO; Lee YM; Lee ES; Kim HS; Park SH
J Cancer Res Clin Oncol; 2010 Feb; 136(2):187-94. PubMed ID: 19655168
[TBL] [Abstract][Full Text] [Related]
2. Methylation of Integrin α4 and E-Cadherin Genes in Human Prostate Cancer.
Mostafavi-Pour Z; Kianpour S; Dehghani M; Mokarram P; Torabinejad S; Monabati A
Pathol Oncol Res; 2015 Sep; 21(4):921-7. PubMed ID: 25743258
[TBL] [Abstract][Full Text] [Related]
3. Aberrant DNA methylation of integrin α4 in human breast cancer.
Do SI; Ko E; Kang SY; Lee JE; Nam SJ; Cho EY; Kim DH
Tumour Biol; 2014 Jul; 35(7):7079-84. PubMed ID: 24756760
[TBL] [Abstract][Full Text] [Related]
4. Aberrant promoter CpG islands methylation of tumor suppressor genes in cholangiocarcinoma.
Uhm KO; Lee ES; Lee YM; Kim HS; Park YN; Park SH
Oncol Res; 2008; 17(4):151-7. PubMed ID: 18773859
[TBL] [Abstract][Full Text] [Related]
5. Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.
Goeppert B; Konermann C; Schmidt CR; Bogatyrova O; Geiselhart L; Ernst C; Gu L; Becker N; Zucknick M; Mehrabi A; Hafezi M; Klauschen F; Stenzinger A; Warth A; Breuhahn K; Renner M; Weichert W; Schirmacher P; Plass C; Weichenhan D
Hepatology; 2014 Feb; 59(2):544-54. PubMed ID: 24002901
[TBL] [Abstract][Full Text] [Related]
6. Methylation profiles of multiple CpG island loci in extrahepatic cholangiocarcinoma versus those of intrahepatic cholangiocarcinomas.
Kim BH; Cho NY; Choi M; Lee S; Jang JJ; Kang GH
Arch Pathol Lab Med; 2007 Jun; 131(6):923-30. PubMed ID: 17550320
[TBL] [Abstract][Full Text] [Related]
7. Aberrant methylation of integrin alpha4 gene in human gastric cancer cells.
Park J; Song SH; Kim TY; Choi MC; Jong HS; Kim TY; Lee JW; Kim NK; Kim WH; Bang YJ
Oncogene; 2004 Apr; 23(19):3474-80. PubMed ID: 14990990
[TBL] [Abstract][Full Text] [Related]
8. NGX6 gene mediated by promoter methylation as a potential molecular marker in colorectal cancer.
Liu M; Peng Y; Wang X; Guo Q; Shen S; Li G
BMC Cancer; 2010 Apr; 10():160. PubMed ID: 20423473
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
[TBL] [Abstract][Full Text] [Related]
10. Methyl-CpG binding protein MBD2 is implicated in methylation-mediated suppression of miR-373 in hilar cholangiocarcinoma.
Chen Y; Gao W; Luo J; Tian R; Sun H; Zou S
Oncol Rep; 2011 Feb; 25(2):443-51. PubMed ID: 21165562
[TBL] [Abstract][Full Text] [Related]
11. DNA copy-number loss on 1p36.1 harboring RUNX3 with promoter hypermethylation and associated loss of RUNX3 expression in liver fluke-associated intrahepatic cholangiocarcinoma.
Dachrut S; Banthaisong S; Sripa M; Paeyao A; Ho C; Lee SA; Kosinski C; Patil MA; Zhang J; Chen X; Sripa B; Pairojkul C
Asian Pac J Cancer Prev; 2009; 10(4):575-82. PubMed ID: 19827872
[TBL] [Abstract][Full Text] [Related]
12. Aberrant DNA methylation at genes associated with a stem cell-like phenotype in cholangiocarcinoma tumors.
Sriraksa R; Zeller C; Dai W; Siddiq A; Walley AJ; Limpaiboon T; Brown R
Cancer Prev Res (Phila); 2013 Dec; 6(12):1348-55. PubMed ID: 24089088
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
14. Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma.
Shu Y; Wang B; Wang J; Wang JM; Zou SQ
World J Gastroenterol; 2011 Aug; 17(29):3407-19. PubMed ID: 21876633
[TBL] [Abstract][Full Text] [Related]
15. DLEC1 methylation is associated with a better clinical outcome in patients with intrahepatic cholangiocarcinoma of the small duct subtype.
Kim Y; Lee K; Jeong S; Wen X; Cho NY; Kang GH
Virchows Arch; 2019 Jul; 475(1):49-58. PubMed ID: 30610381
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression.
Wehbe H; Henson R; Meng F; Mize-Berge J; Patel T
Cancer Res; 2006 Nov; 66(21):10517-24. PubMed ID: 17079474
[TBL] [Abstract][Full Text] [Related]
17. Novel target genes and a valid biomarker panel identified for cholangiocarcinoma.
Andresen K; Boberg KM; Vedeld HM; Honne H; Hektoen M; Wadsworth CA; Clausen OP; Karlsen TH; Foss A; Mathisen O; Schrumpf E; Lothe RA; Lind GE
Epigenetics; 2012 Nov; 7(11):1249-57. PubMed ID: 22983262
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of MGMT promotes proliferation of intrahepatic cholangiocarcinoma by regulating p21.
Chen J; Li Z; Chen J; Du Y; Song W; Xuan Z; Zhao L; Song G; Song P; Zheng S
Clin Transl Oncol; 2020 Mar; 22(3):392-400. PubMed ID: 31264147
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of O6-methylguanine-DNA methyltransferase by promoter CpG island hypermethylation in gastric cancers.
Bae SI; Lee HS; Kim SH; Kim WH
Br J Cancer; 2002 Jun; 86(12):1888-92. PubMed ID: 12085181
[TBL] [Abstract][Full Text] [Related]
20. Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma.
Lee S; Kim WH; Jung HY; Yang MH; Kang GH
Am J Pathol; 2002 Sep; 161(3):1015-22. PubMed ID: 12213730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
